NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/05/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1.29 mln
Earnings Date06/12/2026
EPS
1,377
Exceptional
P / E
0.00
Anomalous
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
0.55
Highly suspicious
Relative Strength
15
/ 100
Significantly lagging
Debt / Equity
0.03
Debt-free
Business Description
Onconetix Inc. is a biotechnology company founded in 2018 and based in Cincinnati, Ohio, that develops and sells medical tools focused on men's health and cancer detection across the United States and Europe. Its main product, Proclarix, is a blood-based test used to help detect prostate cancer, offered through a partnership with LabCorp. The company also works with Immunovia AB to bring a pancreatic cancer screening test called PancreaSure to market.
